THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Sterling Capital Management LLC's Holding History (CIK: 0001329883)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 23,670 Value ($000) $443 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 23,616 Value ($000) $345 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 274 Value ($000) $3 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 642 Value ($000) $6 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 1,176 Value ($000) $11 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 117 Value ($000) $1 Avg Close $8.66 Range $7.44 - $10.42

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	23,670	$443	$16.59	$13.50 - $20.33
Q3 2025	23,616	$345	$12.64	$10.82 - $14.87
Q2 2025	274	$3	$9.72	$7.90 - $11.82
Q1 2025	642	$6	$9.31	$8.35 - $10.90
Q4 2024	1,176	$11	$9.10	$7.88 - $10.26
Q3 2024	117	$1	$8.66	$7.44 - $10.42